These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1972544

  • 21. Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiation.
    Leng L, Yu F, Dong L, Busquets X, Osada S, Richon VM, Marks PA, Rifkind RA.
    Cancer Res; 1993 Nov 15; 53(22):5554-8. PubMed ID: 8221697
    [Abstract] [Full Text] [Related]

  • 22. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
    Constantinou AI, Vaughan AT, Yamasaki H, Kamath N.
    Cancer Res; 1996 Sep 15; 56(18):4192-9. PubMed ID: 8797591
    [Abstract] [Full Text] [Related]

  • 23. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE, Haspel HC, Peretz AM, Sonenberg M, Rifkind RA.
    Cancer Res; 1986 Mar 15; 46(3):1136-41. PubMed ID: 3455880
    [Abstract] [Full Text] [Related]

  • 24. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM, Ramsay RG, Rifkind RA, Marks PA.
    Oncogene; 1989 Feb 15; 4(2):165-73. PubMed ID: 2648254
    [Abstract] [Full Text] [Related]

  • 25. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation.
    Francastel C, Mazouzi Z, Robert-Lézénès J.
    Leukemia; 1992 Sep 15; 6(9):935-9. PubMed ID: 1518304
    [Abstract] [Full Text] [Related]

  • 26. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells.
    Patterson KK, Beckman BS, Klotz DM, Mallia CM, Jeter JR.
    J Cancer Res Clin Oncol; 1996 Sep 15; 122(8):465-75. PubMed ID: 8698746
    [Abstract] [Full Text] [Related]

  • 27. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 28. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
    Gascoyne PR, Becker FF.
    J Cell Physiol; 1990 Feb 01; 142(2):309-15. PubMed ID: 2303526
    [Abstract] [Full Text] [Related]

  • 29. Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.
    Melloni E, Pontremoli S, Michetti M, Sacco O, Cakiroglu AG, Jackson JF, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1987 Aug 01; 84(15):5282-6. PubMed ID: 3474654
    [Abstract] [Full Text] [Related]

  • 30. A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamide.
    Arcangeli A, Fontana L, Crociani O, Cherubini A, Hofmann G, Piccini E, Polvani S, D'Amico M, Carlà M, Olivotto M.
    Leukemia; 2000 Dec 01; 14(12):2112-7. PubMed ID: 11187900
    [Abstract] [Full Text] [Related]

  • 31. Maturation of murine erythroleukemia cells committed to differentiation requires protein kinase C.
    GuptaRoy B, Cohen CM.
    J Biol Chem; 1992 Aug 05; 267(22):15326-33. PubMed ID: 1386358
    [Abstract] [Full Text] [Related]

  • 32. New designed HMBA agents as inducers of erythroleukemia cell differentiation.
    Wang H, Zhang S, Zhou J, Zhang J.
    Chin Med Sci J; 2002 Mar 05; 17(1):27-31. PubMed ID: 12894881
    [Abstract] [Full Text] [Related]

  • 33. Effect of dexamethasone on hexamethylene bisacetamide-induced Friend cell erythrodifferentiation.
    Osborne HB, Bakke AC, Yu J.
    Cancer Res; 1982 Feb 05; 42(2):513-8. PubMed ID: 6173113
    [Abstract] [Full Text] [Related]

  • 34. Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells.
    Melloni E, Pontremoli S, Sparatore B, Patrone M, Grossi F, Marks PA, Rifkind RA.
    Proc Natl Acad Sci U S A; 1990 Jun 05; 87(12):4417-20. PubMed ID: 2352925
    [Abstract] [Full Text] [Related]

  • 35. Constitutive muscarinic receptors are involved in the growth and differentiation of friend erythroleukemia cells.
    Cellai C, Matucci R, Vannucchi AM, Paoletti F.
    J Cell Physiol; 1999 Mar 05; 178(3):333-40. PubMed ID: 9989779
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
    Yamashita T, Eto Y, Shibai H, Ogata E.
    Cancer Res; 1990 Jun 01; 50(11):3182-5. PubMed ID: 2334914
    [Abstract] [Full Text] [Related]

  • 38. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
    Chiang CD, Song EJ, Yang VC, Chao CC.
    Biochem J; 1994 Aug 01; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
    [Abstract] [Full Text] [Related]

  • 39. A vincristine-resistant murine erythroleukemia cell line secretes a differentiation enhancing factor.
    Sparatore B, Patrone M, Salamino F, Passalacqua M, Melloni E, Pontremoli S.
    Biochem Biophys Res Commun; 1990 Nov 30; 173(1):156-63. PubMed ID: 2256910
    [Abstract] [Full Text] [Related]

  • 40. Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein.
    Botling J, Liminga G, Larsson R, Nygren P, Nilsson K.
    Int J Cancer; 1994 Jul 15; 58(2):269-74. PubMed ID: 7913083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.